Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-27 @ 6:24 AM
Study NCT ID:
NCT02987166
Status:
COMPLETED
Last Update Posted:
2020-12-16
First Post:
2016-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDCRT Plus Pembrolizumab in Advanced Malignancies
Sponsor:
James Larner, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
18488
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None